These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5109697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Short-term fibrinolytic treatment in acute myocardial infarction].
    Breddin K, Ehrly AM, Fechler L, Frick D, König H, Kraft H, Krause H, Krzywanek HJ, Kutschera J, Lösch HW, Ludwig O, Mikat B, Rausch F, Rosenthal P, Sartory S, Voigt G, Wylicil P.
    Dtsch Med Wochenschr; 1973 Apr 27; 98(17):861-73. PubMed ID: 4571884
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of streptase (streptokinase) and anticoagulants on the functional state of the thrombocytes of myocardial infarct patients].
    Belousov IuB, Liusov VA.
    Klin Med (Mosk); 1971 Jul 27; 49(7):38-43. PubMed ID: 5151428
    [No Abstract] [Full Text] [Related]

  • 5. [The thrombolytic therapy of recent myocardial infarctions].
    van de Loo J.
    Z Gesamte Inn Med; 1965 Dec 01; 20(23):724-7. PubMed ID: 5333410
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Development and results of thrombolytic therapy].
    Deutsch E, Ebringer H, Lechner K, Pilgerstorfer HW.
    Wien Med Wochenschr; 1971 May 15; 121(20):410-5. PubMed ID: 5566996
    [No Abstract] [Full Text] [Related]

  • 8. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L, Wnukowska M, Dmoszyńska A.
    World Health Organ Tech Rep Ser; 1974 Mar 01; 27(5):463-6. PubMed ID: 4206990
    [No Abstract] [Full Text] [Related]

  • 9. [Therapeutic and prophylactic effectiveness of carbochromen in experimental myocardial infarct].
    Kipshidze NN, Kikawa GM.
    Acta Cardiol; 1974 Mar 01; 29(3):185-202. PubMed ID: 4135425
    [No Abstract] [Full Text] [Related]

  • 10. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L, Wnukowska M, Dmoszyńska A.
    Wiad Lek; 1974 Mar 01; 27(5):463-6. PubMed ID: 4603373
    [No Abstract] [Full Text] [Related]

  • 11. [Myocardial infarct and the practitioner's emergency medical pouch: place of intensain].
    Mazuez J.
    Therapeutique; 1970 Dec 01; 46(10):1049-52. PubMed ID: 5511934
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The use of streptokinase in myocardial infarction].
    Mazur NA.
    Ter Arkh; 1966 Mar 01; 38(3):93-7. PubMed ID: 5991914
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M, Abendschein DR, Ferrini D, Ottani F, Rusticali F, Eisenberg PR.
    Thromb Haemost; 1996 Sep 01; 76(3):339-43. PubMed ID: 8883267
    [Abstract] [Full Text] [Related]

  • 17. Streptokinase in acute myocardial infarction: rationale and preliminary results of a combined therapeutic trial.
    Hale GS.
    Australas Ann Med; 1970 Sep 01; 19 Suppl 1():63-5. PubMed ID: 4919313
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Study of the action of intensain on platelet adhesiveness in ischemic heart disease].
    Nicolaescu V, Hergot L, Cîmpeanu A.
    Med Interna (Bucur); 1972 Nov 01; 24(11):1335-40. PubMed ID: 4650951
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.